Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Jun;61(6):517–521. doi: 10.1136/ard.61.6.517

Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis

J Dawson, H Fewins, J Desmond, M Lynch, D Graham
PMCID: PMC1754108  PMID: 12006324

Abstract

Background: Fibrosing alveolitis (FA) is the most serious pleuropulmonary extra-articular feature of rheumatoid arthritis (RA). Features that predict progression of FA in patients with RA have not yet been determined.

Objective: To identify clinical features that predict progressive FA in patients with RA.

Methods: An unselected cohort of 29 patients with RA and FA confirmed by high resolution computed tomography (HRCT) were studied prospectively for 24 months. Three monthly clinical assessment, four monthly pulmonary function tests, and yearly HRCT scanning was undertaken on these patients. Progressive FA was defined as >15% fall in carbon monoxide transfer factor (TLCO) with evidence of increasing FA on HRCT or death as a result of FA.

Results: During 24 months of follow up 10/29 (34%) patients had progressive FA. Progression on HRCT was seen as acute ground glass exacerbations or increasing reticular pattern lung involvement. Progressive FA was associated with the presence of bibasal crackles (p=0.041), TLCO (p=0.001), and extent (p=0.026) and distribution (p=0.031) of lung involvement on HRCT at initial presentation. When multiple logistic regression was used, only TLCO remained significant. Receiver operator curve analysis was employed to identify presenting TLCO of progressive FA. A TLCO <54% of the predicted value demonstrated 80% sensitivity and 93% specificity in predicting progressive FA.

Conclusions: A TLCO <54% of the predicted value is a highly specific predictor of disease progression.

Full Text

The Full Text of this article is available as a PDF (96.0 KB).

Figure 1 .

Figure 1

Open in a new tab

Receiver operator curve for carbon monoxide transfer factor.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira M., Sakatani M., Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr. 1999 Nov-Dec;23(6):941–948. doi: 10.1097/00004728-199911000-00021. [DOI] [PubMed] [Google Scholar]
  2. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  3. Dawson J. K., Fewins H. E., Desmond J., Lynch M. P., Graham D. R. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax. 2001 Aug;56(8):622–627. doi: 10.1136/thorax.56.8.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fujii M., Adachi S., Shimizu T., Hirota S., Sako M., Kono M. Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography. J Thorac Imaging. 1993 Winter;8(1):54–62. [PubMed] [Google Scholar]
  5. Gay S. E., Kazerooni E. A., Toews G. B., Lynch J. P., 3rd, Gross B. H., Cascade P. N., Spizarny D. L., Flint A., Schork M. A., Whyte R. I. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1063–1072. doi: 10.1164/ajrccm.157.4.9703022. [DOI] [PubMed] [Google Scholar]
  6. Hakala M. Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest. 1988 Jan;93(1):114–118. doi: 10.1378/chest.93.1.114. [DOI] [PubMed] [Google Scholar]
  7. Hutchinson D., Shepstone L., Moots R., Lear J. T., Lynch M. P. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis. 2001 Mar;60(3):223–227. doi: 10.1136/ard.60.3.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Karlson E. W., Lee I. M., Cook N. R., Manson J. E., Buring J. E., Hennekens C. H. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum. 1999 May;42(5):910–917. doi: 10.1002/1529-0131(199905)42:5<910::AID-ANR9>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  9. Katzenstein A. L., Myers J. L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1301–1315. doi: 10.1164/ajrccm.157.4.9707039. [DOI] [PubMed] [Google Scholar]
  10. Raghu G., Mageto Y. N., Lockhart D., Schmidt R. A., Wood D. E., Godwin J. D. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study. Chest. 1999 Nov;116(5):1168–1174. doi: 10.1378/chest.116.5.1168. [DOI] [PubMed] [Google Scholar]
  11. Rajasekaran B. A., Shovlin D., Lord P., Kelly C. A. Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis. Rheumatology (Oxford) 2001 Sep;40(9):1022–1025. doi: 10.1093/rheumatology/40.9.1022. [DOI] [PubMed] [Google Scholar]
  12. Remy-Jardin M., Remy J., Cortet B., Mauri F., Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology. 1994 Nov;193(2):375–382. doi: 10.1148/radiology.193.2.7972746. [DOI] [PubMed] [Google Scholar]
  13. Ryu J. H., Colby T. V., Hartman T. E. Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc. 1998 Nov;73(11):1085–1101. doi: 10.4065/73.11.1085. [DOI] [PubMed] [Google Scholar]
  14. Silman A. J., Newman J., MacGregor A. J. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum. 1996 May;39(5):732–735. doi: 10.1002/art.1780390504. [DOI] [PubMed] [Google Scholar]
  15. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980 Mar;35(3):171–180. doi: 10.1136/thx.35.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wells A. U., Rubens M. B., du Bois R. M., Hansell D. M. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol. 1993 Dec;161(6):1159–1165. doi: 10.2214/ajr.161.6.8249719. [DOI] [PubMed] [Google Scholar]
  17. Xaubet A., Agustí C., Luburich P., Roca J., Montón C., Ayuso M. C., Barberá J. A., Rodriguez-Roisin R. Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998 Aug;158(2):431–436. doi: 10.1164/ajrccm.158.2.9709008. [DOI] [PubMed] [Google Scholar]
  18. Zompatori M., Fasano L., Battista G., Cavina M., Bertaccini P. Evoluzione della fibrosi polmonare idiopatica del grado III di Wells all'esordio. Studio con Tomografia Computerizzata ad alta risoluzione. Radiol Med. 1997 Dec;94(6):611–617. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES